Nancy Lewen

Nancy Lewen is research fellow, CSD Analytical chemistry, Bristol-Myers Squibb.

Articles

Perspectives on Quality Attributes of Drug Products Containing Nanomaterials

Kahkashan Zaidi, PhD;Brent Kleintop;John Hammond;Nancy Lewen;Emmanuel Akala;Anthony Hickey;Jolyon Mitchell;June Liang;Timothy Shelbourn;Katherine Tyner;Eloise Welfare;Norbert Maurer;Munir Hussain;Lawrence Block;Myke Scoggins;Thomas Tice

October 1st 2019

In this article, the contents of a stimulus article produced by the joint subcommittee of the USP Expert Committees on Dosage Forms, Physical Analysis, and Excipients and relevant comments from a workshop session are summarized.

Retirement for Obsolete Heavy Metals Tests

Andrew Teasdale;Nancy Lewen;Elisabeth Corbett;Lina Wong;Shoreh Shabrang

October 3rd 2018

This article discusses the retiring of Ph. Eur. and USP heavy metal assays as well as a means of updating related specifications with minimal regulatory burden.

Pharma Collaboration Proposes Retirement of Obsolete Heavy Metals Tests

Andrew Teasdale;Nancy Lewen;Elisabeth Corbett;Lina Wong;Shoreh Shabrang

September 1st 2018

The authors support the retiring of Ph. Eur. and USP heavy metal assays and propose a means of updating related specifications with minimal regulatory burden.